← Back to Search

Antihistamine

Mometasone + Azelastine, then Mometasone Furoate, then Azelastine Hydrochloride for Hay Fever

Phase 1

Waitlist Available

Research Sponsored by Sandoz

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from time 0 hours (prior to dosing), up to 48 or 72 hours post dose

Awards & highlights

Study Summary

This trial will compare a new medication for allergies in teens and young adults to existing ones.

Eligible Conditions

Hay Fever

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from time 0 hours (prior to dosing), up to 48 or 72 hours post dose

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from time 0 hours (prior to dosing), up to 48 or 72 hours post dose

This trial's timeline: 3 weeks for screening, Varies for treatment, and from time 0 hours (prior to dosing), up to 48 or 72 hours post dose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

AUCinf

AUCt

Cmax

+3 more

Trial Design

3Treatment groups

Experimental Treatment

Group I: Mometasone Furoate, then Azelastine Hydrochloride, then Mometasone + AzelastineExperimental Treatment3 Interventions

Group II: Mometasone + Azelastine, then Mometasone Furoate, then Azelastine HydrochlorideExperimental Treatment3 Interventions

Group III: Azelastine Hydrochloride, then Mometasone + Azelastine, then Mometasone FuroateExperimental Treatment3 Interventions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mometasone Furoate

2005

Completed Phase 4

~190

Azelastine Hydrochloride

2021

Completed Phase 3

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

SandozLead Sponsor

142 Previous Clinical Trials

26,519 Total Patients Enrolled

Media Library

Azelastine Hydrochloride (Antihistamine) Clinical Trial Eligibility Overview. Trial Name: NCT05887843 — Phase 1

Hay Fever Research Study Groups: Mometasone + Azelastine, then Mometasone Furoate, then Azelastine Hydrochloride, Mometasone Furoate, then Azelastine Hydrochloride, then Mometasone + Azelastine, Azelastine Hydrochloride, then Mometasone + Azelastine, then Mometasone Furoate

Hay Fever Clinical Trial 2023: Azelastine Hydrochloride Highlights & Side Effects. Trial Name: NCT05887843 — Phase 1

Azelastine Hydrochloride (Antihistamine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05887843 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide an assessment of the security profile for a regimen involving Mometasone + Azelastine, then Mometasone Furoate, and finally Azelastine Hydrochloride?

"Due to it being a Phase 1 trial, there is only scant evidence of safety and efficacy for Mometasone + Azelastine, Mometasone Furoate, and Azelastine Hydrochloride. Thus our team has assigned them all risk rating of 1."

Answered by AI

Are geriatric patients allowed to participate in this research?

"Patients who meet the criteria of this trial must be aged between 12 and 24. Additionally, 23 studies are available for minors while 45 slots are reserved for those over 65."

Answered by AI

Does this research opportunity extend to me?

"This experiment requires participants to have hay fever and be a part of the 12-24 age bracket. The tried is seeking 60 volunteers in total."

Answered by AI

Is enrollment still open to the public for this experiment?

"According to the records from clinicaltrials.gov, this trial is not actively seeking new participants currently. It was posted on May 29th of 2023 and has since had its details updated lastly on the 24th of that same month. Despite this particular study's status, there are 66 other trials in progress which need patients now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

2023. "Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05887843.